Clinical Experiences of Using Circulating Tumor DNA

In this third part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, highlights the in practice experiences in using circulating tumor DNA for merkel cell carcinoma (MCC).

Related Videos
Related Content

Leukemia-Related Cutaneous Findings

January 30th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

The Immune Profile of Merkel Cell Carcinoma

January 5th 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

Treatment and Diagnosis of Merkel Cell Disease

January 3rd 2023

Adjuvant Treatment for Merkel Cell Carcinoma

December 27th 2022

Leukemia-Related Cutaneous Findings

January 30th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

The Immune Profile of Merkel Cell Carcinoma

January 5th 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

Treatment and Diagnosis of Merkel Cell Disease

January 3rd 2023

Adjuvant Treatment for Merkel Cell Carcinoma

December 27th 2022

Leukemia-Related Cutaneous Findings

January 30th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

The Immune Profile of Merkel Cell Carcinoma

January 5th 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

Treatment and Diagnosis of Merkel Cell Disease

January 3rd 2023

Adjuvant Treatment for Merkel Cell Carcinoma

December 27th 2022
Advertise
Contact Us
Job Board
Do Not Sell My Information
Terms and Conditions
Privacy Policy
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.